1999
DOI: 10.1046/j.1365-2826.1999.00332.x
|View full text |Cite
|
Sign up to set email alerts
|

Localization of Vasopressin (V1a) Receptor Binding and mRNA in the Rhesus Monkey Brain

Abstract: Centrally released arginine vasopressin (AVP) has been associated with various behavioural and cognitive effects, such as scent marking, aggression, and memory, which are believed to be mediated by the V1a subtype of the vasopressin receptor. Although the distribution of V1a receptors is conserved in a few brain regions, the pattern of expression of this receptor is, in general, highly species-specific. We have used receptor autoradiography with the linear V1a receptor ligand (125I-Phenylacetyl-D-Tyr(Me)-Phe-G… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
84
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 122 publications
(88 citation statements)
references
References 35 publications
3
84
1
Order By: Relevance
“…However, it is also possible that birds possess two or more VT receptors in the brain, with one type being more similar to the mammalian V 1a receptor (which would be selectively targeted by the linear 125 I-V 1a antagonist). Finally, as in the estrildid finches examined here, robust binding for the linear 125 I-V 1a antagonist is typically observed in the mammalian LS, with large differences in density occurring across species (Insel, 1992;Insel et al, 1994;Wang et al, 1997;Young et al, 1997Young et al, , 1999Bester-Meredith et al, 1999). …”
mentioning
confidence: 58%
See 2 more Smart Citations
“…However, it is also possible that birds possess two or more VT receptors in the brain, with one type being more similar to the mammalian V 1a receptor (which would be selectively targeted by the linear 125 I-V 1a antagonist). Finally, as in the estrildid finches examined here, robust binding for the linear 125 I-V 1a antagonist is typically observed in the mammalian LS, with large differences in density occurring across species (Insel, 1992;Insel et al, 1994;Wang et al, 1997;Young et al, 1997Young et al, , 1999Bester-Meredith et al, 1999). …”
mentioning
confidence: 58%
“…Incubation concentrations and durations for each peptide were: 125 I-SG, 30 pM for 60 min; 125 I-VIP, 50 pM for 90 min; and linear 125 I-V 1a antagonist, 50 pM for 75 min. Concentrations were selected through pilot testing using a range of concentrations from the literature, and are similar to those used in previous investigations (e.g., Hof et al, 1991;Young et al, 1999;Bakshi et al, 2002). For 125 I-SG binding, slides were then rinsed 2 × 4 min in icecold Tris-MgCl 2 buffer, dipped in distilled water and dried under a cool stream of air.…”
Section: Quantitative Autoradiographymentioning
confidence: 99%
See 1 more Smart Citation
“…Both oxytocin and vasopressin have been localized to the amygdala, both with respect to receptors and to the effects of these neuropeptides on specific neuronal populations, e.g., [38] and [125]. Oxytocin in the medial amygdala has also been implicated in the processes underlying early social recognition in mice [27].…”
Section: Neurochemical Control Of Cryingmentioning
confidence: 99%
“…In these latter regions, arginine vasopressin exerts a neuromodulatory role via an action on specific receptors, i.e. V 1a and V 1b (Lolait et al, 1995;Vaccari et al, 1998;Young et al, 1999), which are widely distributed in the central nervous system (Lolait et al, 1995;Morel et al, 1992). Several findings suggest that arginine vasopressin may be involved in the modulation of emotional processes primarily via the V 1b receptor subtype.…”
Section: Effect Of the Arginine Vasopressin V 1b Receptor Antagonist mentioning
confidence: 99%